Mixing in a Compounding Pharmacy in the 21st Century
Download in electronic PDF format for $75
Abstract: When it comes to combining ingredients for topical preparations, compounding pharmacists utilize either the manual methods such as a spatula and pill tile or a mortar and pestle, typically an electronic mortar and pestle. If a topical preparation must be pre-ground or requires trituration, or any level of particle-size reduction, historically the manual method of combining ingredients in such a preparation would include the initial use of a mortar and pestle; however with micronized substances this is not as much a concern today as in the past. There is, of course, the concern of a lack of reproducibility, knowing that each compounder might utilize the equipment differently, would mix for varying times, and would also mix with varying amounts of physical pressure applied to the pestle. If the discipline of uniform usage is great enough in the lab, this method could probably produce consistent results, but, because of the preparation and cleanup time and the fact that newer technology is available, this method is not recommended as the common compounding method in a compounding pharmacy that does more than a handful of compounded topical preparations per week. This article is not meant to say these methods are not appropriate, but preferable in order to provide a cleaner, more efficient, and more reproducible lab environment.
Related Keywords:
Rob Standridge, DPh, BSPharm, topical preparations, electronic mortar and pestle, equipment, technology, unguators, mixers, grinding, particle size reduction, suspensions, emulsions, gels, Gako, closed mixing systems
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Mixing in a Compounding Pharmacy in the 21st Century
Standridge Rob
|
Nov/Dec 2015
Pg. 479-484
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
|
Jul/Aug 2004
Pg. 269-274
|
The Mortar and Pestle
Allen Loyd V Jr
|
Mar/Apr 1997
Pg. 80-82
|
Technology Spotlight: Electronic Balances with Printer and Draft Shield
Wesolowski Paul
|
Mar/Apr 2003
Pg. 120-123
|
High-tech Compounding: State-of-the-art Equipment Improves Products and Profit
Allen Loyd V Jr
|
Nov/Dec 2001
Pg. 412-419
|
Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
|
May/Jun 2004
Pg. 206-209
|
The Basics of Compounding Emulsions, Part 2
Allen Loyd V Jr
|
May/Jun 2001
Pg. 198-201
|
Technology Spotlight: Electric Mixing Machines
Schneider Gary
|
May/Jun 2002
Pg. 188
|
PostScription: Moving Pharmacy Compounding into the 21st Century and Beyond
Allen Loyd V Jr
|
Sep/Oct 2006
Pg. 400
|
Validation Study of the Unguator, an Apparatus for Compounding Dermatological Preparations
Piette Marie, Stassen Thibaut, Kinget Renaat, Delattre Luc
|
Nov/Dec 2006
Pg. 469-477
|
Particle Size Distribution of Propofol Injection from Ampules and Vials: The Benefits of Filitration
Driscoll David F, Deaconess Beth Israel, Lawrence Kenneth R, Lewis Keith, Bistrian Bruce R
|
Mar/Apr 1997
Pg. 118-120
View Sample |
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 44
|
Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Jan/Feb 2021
Pg. 47
|
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 415
|
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
Sep/Oct 2021
Pg. 416
|
Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
|
Nov/Dec 2021
Pg. 505
|
Stability of Allopurinol in Extemporaneously Compounded Oral Suspensions with Oral Mix and Oral Mix SF
Friciu Mihaela, Cull Erica, Leclair Grégoire
|
Sep/Oct 2024
Pg. 408-412
|
Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
|
May/Jun 2018
Pg. 235
|
Return to Top |